Online / Physical Event

3rd Euroscicon conference on

Cancer Stem Cell & Oncology Research

Theme: Latest Innovation in Cancer Treatment stem cell and Oncology research

Event Date & Time

Event Location

Singapore City , UK

Program Abstract Registration Awards

18 years of lifescience communication

441753260031

Performers / Professionals From Around The Globe

Conference Speaker

ELIZABETH RUFUS

Vellore Institute of Technology
India

Conference Speaker

BETTINA MARIA HALLER


Austria

Conference Speaker

XIANMING MO

Sichuan University
China

Conference Speaker

SITI MUNIRA ABD JALIL

Government National Cancer Institute
Malaysia

Conference Speaker

XU CHEN

University of the Rockies
USA

Conference Speaker

GERALD C.HSU

Medical Research Scientist
USA

Conference Speaker

WIM DE MAREZ

European BioImmun (G)en Medicine Association
France

Conference Speaker

CHRISTOS DROSSINAKIS

Iawg-InternationaleAkademiefür Wissenschaftliche
Germany

Conference Speaker

IGNAT IGNATOV

Scientific Research Center of Medical Biophysics(SRCMB)
Bulgaria

Conference Speaker

GILBERT GLADY

European Bio Immune (G)ene Medicine Association
France

Conference Speaker

MYAT THU THU WIN

AIMST University,
Malaysia

Conference Speaker

GIORGIO SEANO

Institut Curie Research Center
France

Tracks & Key Topics

Cancer Stemcell 2021

About Event

 “3rd EuroSciCon Webinar on Cancer Stem Cell & Oncology Research (Cancer Stem Cell 2021)” is hosted by EuroSciCon” and focuses on scientific excellence, advantageous to both Industrial and Academic Scientists in Cancer stem cell and Oncology research. EuroSciCon is the longest running independent life science events company with a predominant academic client base. Our multi-professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.

On behalf of Cancer Stem Cell 2021, we are pleased to invite Academicians, Oncologists, Pathologists, Cancer & Oncology Societies Professionals, Bio-Medical Company professionals, Corporate Cancer Research Professional, Research Scholars, Pharmacists, Business Entrepreneurs, Software Developing Companies. Medical Devices Companies, Biotechnology Companies and related fields, Teachers, Business delegates and Young researchers across the globe to attend “Cancer Stem Cell-2021” to be held on August 02-03, 2021. The Webinar highlights the theme “Latest Innovation in Cancer Treatment stem cell and Oncology research”. The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (Post) Doctoral Junior Scientists will be considered.

Cancer Stem Cell -2021 will provide unparalleled prospects to associate with leading oncologists, doctors, scientists, academicians, specialists & business associates from around the world. As the theme of the webinar depicts,  Latest Innovation in Cancer Treatment stem cell and Oncology research serves as a global platform to converse concerning the current developments, recent advances, new approaches and future approaches in the field of cancer stem cell& Oncology research.

Importance and scope:

Radiation therapy is one of the prominent therapies used today in the treatment of cancer. Developed countries such as U.S., Europe have already considered radiotherapy procedure as the gold standard for cancer treatment. Radiotherapy refers to therapeutic procedures using high-energy electromagnetic waves or radioactive particulates to thwart abnormal cell growths and repair different physiological abnormalities within the human body.  3rd Euroscicon Conference on Cancer Stem Cell & Oncology Research (Cancer Stem Cell 2021) will be the best platform for Radiologists, Oncologists, Researchers working in this field to connect and exchange ideas.

Tracks & Sessions

Track 1: Cancer Stem Sell

The Cancer Stem Cell (CSC) speculation hypothesizes the presence of a little populace of disease cells with characteristic properties taking into account protection from traditional radio-chemotherapy regiments and expanded metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with expanded tumour repeat, metastatic spread, and generally poor patient result over various malignant growth subtypes. Separation of CSCs has been accomplished through use of cell surface markers, while the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.

Track 2: Cancer Research

Cancer Research helps to identify causes, and develop strategies for prevention, diagnosis, treatment and cure. Cancer Research could involved Scientists from Chemistry, Biochemistry, Biomedical Engineering, Physiology or Molecular background.

Types of Research

  • Fundings in Cancer Research
  • Participation of Patients in Cancer Research
  • Future of Cancer Research

Track 3: Stem cell & Cancer Research

Stem cell transplants include process that restores the blood-forming stem cells in people who have had destroyed their cells by the very high doses of chemotherapy or radiation therapy that were used to treat certain cancers. Different types of Stem cell Transplants include Autologous, Allogeneic and Syngeneic

  • Use of Stem Cell in Cancer Treatment
  • Stem Cell Transplant Procedures
  • Stem Cell Transplant Side Effects
  • Types of Stem Cell Transplant
  • Challenges in Stem Cell Transplant

Track 4: Stem cells

Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms.In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.

Track 5: Bio-markers of Cancer Stem Cells

Liver cancer is the fifth most normally analysed harm and the second most incessant reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours worldwide. Research into the molecularbiology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have potential predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to portray HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.

Track 6: Cancer Stem Cell Treatments

Cancer treatments against tumour, chemo-and radiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumour formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of CSCs. On-going distinguishing proof of surface markers and comprehension of atomic element is related with CSC phenotype, assisted with the plan of viable medicines.

Track 7: Cancer

Cancer is a disease that leads to abnormal growth of a cell and has the potential to spread to different parts of body. Whereas, in case of benign tumors, they do not spread to the body, but remain at specific part only. There are many types of Cancer including, Skin Cancer, Prostate Cancer, Lung Cancer, Stomach Cancer, etc.

Track 8: Cancer Survivorship

A cancer patient who has had cancer is know as a Cancer Survivor. Cancer Survivorship has 2 meanings, having no signs of cancer after the treatment has been completed and secondly living with cancer.

  • Phases of Survivorship
  • Cancer patients survival rates
  • Survivorship Care Plans
  • Care ; before & after Treatment

Track 9: Cancer & Oncology Case Reports

Case Reports are detailed report of the patient who has been diagnosed with the disease. This report includes signs & symptoms, diagnosis, treatment methods of that particular patient. Some of the case reports may contain a Review of Literature of previous reported cases of some patients.

Track 10: Side effects of Cancer Treatment

There are various type of side effects of Cancer Treatments, depending on the type of Cancer caused. For example chemotherapycauses anemia, constipation, fatigue, hair loss.

  • Long term side effects of Cancer Treatment
  • Side effects of cancer drugs
  • Neutropenia
  • Cancer Pain
  • Cognitive Problems

Track 11: Cancer Pathophysiology

Cancer occurs due to uncontrolled growth of cells. In Dysplasia a cell differs from the normal parent cell in size and shape. Metaplasia is the starting stage of Dysplasia. In Hyperplasia the cell count increases.

Track 12: Cancer Awareness

According to the National Cancer Institute, the second leading cause of death is Cancer in the US. Information and education about Cancer are the key to cancer prevention, early detection of Cancer and to have the best treatment options.

  • Food Habits and Cancer
  • Public Education
  • Awareness Programs
  • Cancer Research Awareness

Track 13: What Causes Cancer

Majority of the Cancers take place due to genetic changes, which occurs due to mutagens (cancer-causing agents). Chemical such as, Nitrosamines could act as a potential Mutagen. Ionizing and Non-ionizing radiations both lead to cancer. Examples include; UV rays, X-rays.

Track 14: Stages of Cancer

There are 4 Stages of Cancer, which include Stage 0 (There is no cancer, but some abnormal cells that may give rise to cancerous cells) Stage 1 (Cancer is located in small area) Stage 2 & 3 (Cancer has spread to larger area including tissues and lymph nodes), Stage 4 (Cancer has spread to many parts of the body)

  • Different Stages of Cancer
  • Reoccurrence of Cancer
  • Local & Malignant Cancer
  • Various treatment measures at different stages of cancer

Track 15: Anti-Cancer Drugs

Anticancer drug is also known as Antineoplastic drug. It is effective for cancerous cell treatment. Alone anti cancerous drug could be used to treat Cancer or along with the combination of Surgery, Chemotherapy or Radiation Therapy. The use of Anti-drug medicine depends on the type of cancer involved. For example, for Prostate Cancers, drugs that inactivate androgens (male sex hormone) could be used. Examples of some of the anticancer drugs are, Altretamine, Bleomycin, Busulfan.

  • Discouvery of Anti- Cancerous Drugs
  • Classes of Anti Cancerous Drug
  • Targets of Anti- Cancerous Drugs
  • Pharmacokinetics of Anti-Cancerous Drugs
  • Side Effects of Anti Cancerous Drug
  • Efficacy of Anti Cancerous Drug

Track 16: Types of Cancer

There are many types of Cancer out of which some common types of Cancer include, Breast Cancer, Prostate Cancer, Lung Cancer, Skin Cancer, Ovarian Cancer, Lymphoma, Pancreatic Cancer, Bone Cancer. The major cause of Lung Cancer includes higher smoking rates, which directly affect the lungs.

Track 17: Cancer Immunology

Cancer immunology helps us to understand the response of the immune system while the cancer progression has begun to occur. Cancer immunotherapy utilizes the immune system for treating the cancer. Cancerimmunotherapy proves to be more effecting, lost lasting and more specific as compared to other methods.

Track 18: Cancer Nursing

Oncology Nurse is a Specialist who take cares of Cancer patients. Oncology nursing care could be defined as the special care and completing the needs of patients during the time of their disease, while may involve some screening methods and preventive measures that should be taken care of.

Track 19: Cancer Diagnosis

Cancer Screening at the earliest stage of Cancer helps to cure the cancer at the very earliest stage of Cancer. Cancer Diagnosis include tests such as, Physical examination, which may be visible (abnormalities such as lumps, change in skin color or enlarged organ). It also includes, Laboratory tests, Imaging or Biopsy.

  • Tests used for Cancer Diagnosis
  • Cancer Diagnosis and cure of cancer
  • Cancer stage and Diagnosis of Cancer
  • Future expansions in Cancer Diagnosis

Track 20: Clinical research and trials in stem cells and cancer

Clinical preliminaries are broadly perceived for real advances in Cancer treatment because of Developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease (GvHD), a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells assault solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia (GVL) impact restorative impact in which transplanted invulnerable cells assault leftover leukaemia or other tumour cells

Track 21: Stem Cell Biology and advances

Structural microorganisms have the surprising potential to form into a wide range of cell types, basically unbounded to recharge different cells as long as the individual or creature is as yet alive, offering gigantic any expectation of relieving Alzheimer's infection, fixing harmed spinal lines, treating kidney, liverand lung maladies and making harmed hearts entirety. Up to this point, researchers essentially worked with two sorts of undifferentiated organisms from creatures and people: embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem cells with various innovations. The audit will quickly talk about the on-going advances here.

  • Stem cells in endocrinology
  • Liver stem cells and regeneration
  • Early embryonic development
  • Neural stem cells and regeneration
  • Blood stem cells and regeneration
  • Muscle (cardiac and skeletal) stem cells and regeneration
  • Totipotency, pluripotency and multipotency  

Track 22: Umbilical Cord Stem Cells

Moral and logical issues encompass both embryonic and fatal Cord Stem cells and frustrate their across the board usage. Interestingly, foundation microorganisms recuperated postnatal from the umbilical line, including the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest wellspring of cells that are fit for framing a wide range of cell types (i.e., they are "multi-potent"). This survey will centre around the umbilical rope determined immature microorganisms and contrast those cells and grown-up bone marrow-inferred melancholy undifferentiated organisms.

  • Corneal disease
  • Umbilical cord blood transplant

Track 23: Stem Cell And Tissue Homeostasis

Tissue homeostasis depends on the precise direction of substantial foundational microorganism movement. Substantial undeveloped cells need to react to tissue harm and multiply as per tissue prerequisites, while staying away from over-multiplication. The administrative systems engaged with these reactions are presently being disentangled in the intestinal epithelium of Philosophical, giving new understanding into procedures and components of undeveloped cell direction in obstruction epithelial.

  • SCs and their niches
  • Hematopoietic SCs
  • SCs and the origin of intestinal cancer

Track 24: Stem Cell Aging

Maturing tissues encounter a dynamic decrease in homeostatic and regenerative limits, which has been credited to degenerative changes in tissue-particular foundation microorganisms, undifferentiated organism specialties and fundamental signals that manage undeveloped cell action. Understanding the sub-atomic pathways associated with this age-subordinate crumbling of immature microorganism capacity will be basic for growing new treatments for maladies of maturing that objective the particular reasons for age-related utilitarian decay. Here we investigate key sub-atomic pathways that are generally irritated as tissues and undifferentiated organisms age and savage.

  • Theories of aging
  • Theories of biological aging
  • Proximate theories of biological aging
  • Alzheimer‘s disease
  • Cardiovascular diseases

Track 25: Stem Cell Therapy

Essential microorganisms are the body's rough materials cells from which each other cell with particular limits are created. New mother cells or stem cells either ended up being new undifferentiated cells (self-restoration) or wind up stem cells (division) with a more specific limit, for instance, platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the trademark ability to make new cell types.

  • Acute Lymphoblastic Leukaemia
  • Acute Megakaryocytic Leukaemia
  • Acute Myelomonocytic Leukaemia
  • Lymphoma Cancer
  • Immune Cell Therapy
  • Allogeneic transplantation.
  • Advances in Bone Marrow Stem Cell

Track 26: Recent advances in Stem Cell

Immature microorganisms have the amazing potential to form into various cell types, basically unbounded to renew different cells as long as the individual or creature is as yet alive, offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung sicknesses and making harmed hearts entirety. Up to this point, researchers essentially worked with two sorts of undeveloped cells from creatures and people: embryonic undifferentiated cells and non-embryonic "substantial" or "grown-up"  microorganisms. On-going achievement makes it conceivable to change over or "reinvent"specific grown-up cells to expect stem-like cells with various advancements. The survey will quickly talk about the on-going advances here.

  • Embryonic stem cells
  • Somatic cell nuclear transfer (SCNT)
  • Induced pluripotent stem cell (iPSC)
  • Stimulus-triggered acquisition of pluripotency (STAP)
  • Adult Stem Cells
  • Adult Neural Stem Cells

Track 27: Epidermal Stem Cells 

The skin continually re-establishes itself for the duration of grown-up life, and the hair follicle experiences an interminable cycle of development and degeneration.   microorganisms (StemCell's) dwelling in the epidermis and hair follicle guarantee the support of grown-up skin homeostasis and hair recovery, however they likewise take part in the fix of the epidermis after wounds.

  • Stem cells with in adult skin epithelium
  • Signalling and stem cell fate specification in the skin
  • Bone Morphogenetic Protein Signalling
  • Notch Signalling

Track 28: Stem Cell Renewa

In numerous tissues, mammalian maturing is related with a decrease in the replicative and utilitarian limit of physical immature microorganisms and other self-recharging compartments. Understanding the premise of this decay is a noteworthy objective of maturing research. . Such methodologies incorporate endeavours to shield undifferentiated organisms from age-advancing harm, to 'revive' foundation microorganisms using pharmacologicspecialists that moderate maturing incited modifications in flagging, and to supplant lost undeveloped cells through regenerative drug approaches. Some progress has been made in every one of these fields in the course of the most recent year and a half incorporating advances in the generation of contributor particular all-powerful undifferentiated organisms through prompted diplomat (iPS), gains in our comprehension of how tumour silencer flagging is controlled in self-restoring compartments to direct maturing, and further show of extracellular 'milieu' factors that bother undeveloped cell work with age.

  • Regenerative medicine and iPS    
  • Somatic self-renewal and aging
  • somatic stem and progenitor cell aging

Track 29: Ethics considerations in stem cell therapy

Stem Cell Research offers incredible guarantee for understanding fundamental components of human advancement and separation, and additionally the expectation for new medications for illnesses, for example, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In any case, human Stem Cell (hSC) inquires about additionally raises sharp moral and political contentions. The reconstructing of substantial cells to deliver instigated pluripotent undifferentiated organisms keeps away from the moral issues particular to embryonic microorganism examine. In any hSC look into, be that as it may, troublesome problems emerge with respect to delicate downstream research, agree to give materials for hSC explore, early clinical preliminaries of hSC treatments, and oversight of hSC inquire about. These moral and strategy issues should be talked about alongside logical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic investigation of these issues and how they are tended to in current approaches.

  • Multi-potent Stem Cells
  • Embryonic Stem Cell Research
  • Somatic Cell Nuclear Transfer (SCNT)
  • Induced Pluripotent Stem Cells (iPS Cells)
  • Stem Cell Clinical Trials

Track 30: Advance  in developmental biology and stem cells

Developmental biology (counting embryology) is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, transformative components, neurobiology, and frameworks science every has its heritage in formative science. In addition, formative science keeps on moving on, maturing off more teaches, while holding its very own character. While its relative controls separate into sciences with a limited arrangement of standards, precedents, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the developmental point of view is being reasserted as a critical research program.

  • The emergence of cellular heterogeneity within the PSU
  • The PSU and tissue compartmentalisation
  • Tissue compartmentalisation
  • Oncogenic perturbation of stem cell behaviour
  • Compartmentalisation and heterogeneity beyond the epidermis

MARKET ANALYSIS

Euroscicon Ltd invites all the participants through the globe to join at EuroSciCon Conference on Cancer Stem Cell & Oncology Research which is going to be held during August 05-06,2020, Singapore. which will include keynote presentations, Oral talks, Poster presentations, and Exhibitions. Cancer Stem Cell 2020 is a specially designed cluster conference. The main theme of the conference is Advanced Research and Developments in Oncology & Cancer Stem Cells” which covers a wide range of critically important sessions.

For More details please visit: https://cancerstemcell.euroscicon.com/

 Importance & Scope

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease  it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. And only a global search for answers will help us get to grips with this disease. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

Cancer stem cell 2020 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Tumor Virology, Cancer Nanotechnology, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

Why Seoul?

Seoul, officially the Seoul Special Metropolitan City, is the capital and largest metropolis of South Korea. Seoul is the hub of Cancer Institutes and center for Cancer Research. In recent years, the number of international students for Cancer Research at Seoul's universities has risen rapidly.

Market Analysis Report:

Cancer is a disease characterized by the abandoned growth and spread of abnormal cells. If the growth of abnormal cells is not controlled, it can result in death. In Worldwide, one in seven deaths is due to cancer.  cancercauses more deaths than AIDS, tuberculosis, and malaria. According to income when countries are grouped, cancer is the second leading cause of death in high-income countries (following cardiovascular diseases) and the third leading cause of death in low- and middle-income countries (following cardiovascular diseases and infectious and parasitic diseases).

Cancer Diagnostics Market:

The global market size of cancer diagnostics is expected to reach $22.7 billion from $7.1 billion in 2015. Growing prevalence of oncologic cases, constant technological innovations in diagnostics, and increasing requirement for effective screening tests are some of the main factors prompting the demand for screening tools across the world.

Rising awareness and supportive government enterprises are some other factors that are anticipated to increase the growth of the sector during the forecast period. The global cancer diagnostics market is fragmented based on technology, application, and region.  Increase in aging population and cancer cases are likely to create a huge opportunity for cancer diagnostics.

Cancer Diagnostic Market, By Technology

 Based on technology, the cancer diagnostics market is divided into instrument-based and platform-based. In 2015, the instrument-based segment is predicted to account for a major share of the cancer diagnostics market, by product.

1) Platform Based:

  • In situ Hybridization
  • Flow Cytometry
  • Next-generation Sequencing
  • Microarrays
  • Others

2) Instrument Based:

  • Biopsy
  • Mammography
  • PET
  • Ultrasound
  • MRI
  • CT

Cancer Diagnostic Market, By Region

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.

Some of the major performers in the global cancer diagnostics system market are:

  • Sanofi (France)
  • Novartis (Germany)
  • Pfizer Inc. (U.S.)
  • Eli Lilly & Company (U.S.)
  • ImClone Systems Inc. (U.S.)
  • GlaxoSmithKline (U.K)
  • AstraZeneca (U.K)
  • Schering-Plough (U.S.)
  • Boehringer Ingelheim (Germany)
  • Bristol-Myers Squibb
  • Teva Pharmaceuticals Industries (Japan)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Merck & Co., Inc. (U.S.)
  • Chemo Espana SL (Spain)
  • CELGENE CORPORATION (U.S.)
  • Amgen Inc (U.S.)
  • Bayer AG (Germany)
  • Takeda Pharmaceutical Company Limited (Japan)

 Major Associations Worldwide

  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • American Society of Paediatric Haematology/Oncology
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • International Cancer Research Partnership (ICRP)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • Cancer Society of New Zealand
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • Australian Prostate Cancer Research
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • German Cancer Research Centre

Major Medical Universities

Worldwide

Cancer related companies:

Roche | Sanofi | Johnson & Johnson | Merck & Co. (MSD) | Novartis AbbVie | Gilead SciencesGlaxoSmithKline (GSK) | Amgen | Pfizer | F. Hoffmann-La Roche Ltd | Celgene  Corp |Novartis AG | Bristol-Myers Squibb Co | Samsung Medical Cente

Learn More

Major Cancer Stem cell and Oncology research Associations in Singapore:

Ajou University | Catholic Kwandong University | Catholic University of Daegu Catholic University of Korea | CHA University | Cheju National University | Chonbuk National University | Chonnam National University Chosun University Chung-Ang University | Chungbuk National University | Chungnam National University | Dankook University Dong-A University,  | Dongguk University,  | Eulji University,  | Ewha Womans University | Gachon University of Medicine and Science | Gyeongsang National University | Hallym University Hanyang University Inha University | Inje University | Kangwon National University Keimyung University Konkuk University | Konyang University Korea University | Kosin University | Kyung Hee University | Kyungpook National University Pusan National University | Seonam University | Seoul National University | Soonchunhyang University | Sungkyunkwan University | University of Ulsan | Wonkwang University | Yeungnam University | Yonsei University Seoul National University | Korea University

Top Universities for Cancer Stem Cell & Oncology Singapore:

Yale University | Emory University | Karolina University | John Hopkins University | University Of Wisconsin | Kings College London| Harvard University | University of Oxford | University of Cambridge | Stanford University | Cambridge University

Top Universities for Cancer Stem Cell & Oncology in Asia:

The University of Tokyo | National University of Singapore (NUS) | Kyoto University Yonsei University | Shanghai Jiao Tong University | Nanyang Technological University (NTU) | Chulalongkorn University | Tohoku University | Tokyo Medical and Dental University Kyushu University | Nagoya University | University of Science and Technology of China| University of Hong Kong (HKU) Peking University Seoul National University (SNU) National Taiwan University (NTU) | Osaka University | Tsinghua University | The Chinese University of Hong Kong (CUHK) Fudan University | The Hong Kong University of Science and Technology (HKUST) Taipei Medical University | Mahidol University | KAIST - Korea Advanced Institute of Science and Technology

Journals for Cancer Stem Cell & Oncology:

Cancer Surgery Journal | Carcinogenesis & Mutagenesis Journal | Cervical Cancer Journal | Chemotherapy Journal | Colorectal Cancer Journal | Gastrointestinal Cancer Journal | Integrative Oncology Journal | Leukaemia Journal| Journal of Neoplasm Journal of Carcinogenesis & Mutagenesis, Epidemiology: Open Access | Journal of Vaccines & Vaccination | Journal of Cell Biology Journal of  Stem  Cell Reports | Journal of Cell Death and Differentiation, Aging Cells, Molecular Biology of the Cell | Cancer Diagnosis Journal

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!